In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
The price of Dyne Therapeutics Inc (NASDAQ: DYN) closed at $9.02 in the last session, down -4.04% from day before closing price of $9.4. In other words, the price has decreased by -$4.04 from its previous closing price. On the day, 1.58 million shares were traded. DYN stock price reached its highest trading level at $9.5993 during the session, while it also had its lowest trading level at $8.95.
Ratios:
We take a closer look at DYN’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 20.35 and its Current Ratio is at 20.35. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.03.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Bernstein on June 24, 2025, initiated with a Mkt Perform rating and assigned the stock a target price of $13.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jul 14 ’25 when Cox John bought 100,000 shares for $9.11 per share. The transaction valued at 911,000 led to the insider holds 242,179 shares of the business.
Scalzo Richard William bought 1,330 shares of DYN for $19,619 on Jun 11 ’25. On Jun 11 ’25, another insider, Beskrovnaya Oxana, who serves as the Officer of the company, bought 2,132 shares for $14.75 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DYN now has a Market Capitalization of 1276735872 and an Enterprise Value of 427943808.
Stock Price History:
The Beta on a monthly basis for DYN is 1.08, which has changed by -0.79115534 over the last 52 weeks, in comparison to a change of 0.13161862 over the same period for the S&P500. Over the past 52 weeks, DYN has reached a high of $47.45, while it has fallen to a 52-week low of $6.36. The 50-Day Moving Average of the stock is -19.48%, while the 200-Day Moving Average is calculated to be -49.67%.
Shares Statistics:
According to the various share statistics, DYN traded on average about 3.00M shares per day over the past 3-months and 3477040 shares per day over the past 10 days. A total of 113.63M shares are outstanding, with a floating share count of 106.08M. Insiders hold about 25.01% of the company’s shares, while institutions hold 67.34% stake in the company. Shares short for DYN as of 1749772800 were 20621906 with a Short Ratio of 5.45, compared to 1747267200 on 23198935. Therefore, it implies a Short% of Shares Outstanding of 20621906 and a Short% of Float of 20.86.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The performance of Dyne Therapeutics Inc (DYN) in the stock market is under the watchful eye of 13.0 analysts actively contributing to its current rating.The consensus estimate for the next quarter is -$0.95, with high estimates of -$0.77 and low estimates of -$1.16.
Analysts are recommending an EPS of between -$3.25 and -$4.52 for the fiscal current year, implying an average EPS of -$3.9. EPS for the following year is -$3.81, with 14.0 analysts recommending between -$2.81 and -$4.81.
